Does NIVOLUMAB Cause Flushing? 154 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 154 reports of Flushing have been filed in association with NIVOLUMAB (OPDIVO). This represents 0.2% of all adverse event reports for NIVOLUMAB.
154
Reports of Flushing with NIVOLUMAB
0.2%
of all NIVOLUMAB reports
5
Deaths
40
Hospitalizations
How Dangerous Is Flushing From NIVOLUMAB?
Of the 154 reports, 5 (3.2%) resulted in death, 40 (26.0%) required hospitalization, and 9 (5.8%) were considered life-threatening.
Is Flushing Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NIVOLUMAB. However, 154 reports have been filed with the FAERS database.
What Other Side Effects Does NIVOLUMAB Cause?
Death (11,216)
Malignant neoplasm progression (9,363)
Off label use (5,208)
Diarrhoea (4,692)
Fatigue (3,709)
Pyrexia (3,454)
Intentional product use issue (3,297)
Rash (2,816)
Nausea (2,805)
Decreased appetite (2,619)
What Other Drugs Cause Flushing?
DIMETHYL (10,681)
TREPROSTINIL (3,166)
TECFIDERA (2,385)
AMBRISENTAN (1,741)
DALFAMPRIDINE (1,605)
DIROXIMEL (1,518)
INFLIXIMAB (1,488)
PACLITAXEL (1,397)
GLATIRAMER (1,291)
EPOPROSTENOL (1,256)
Which NIVOLUMAB Alternatives Have Lower Flushing Risk?
NIVOLUMAB vs NIVOLUMAB\RELATLIMAB-RMBW
NIVOLUMAB vs NIZATIDINE
NIVOLUMAB vs NOMEGESTROL
NIVOLUMAB vs NORDAZEPAM
NIVOLUMAB vs NOREPINEPHRINE